Molecular cytogenetic mapping of 24 CEPH YACs and 24 gene-specific large insert probes to chromosome 17

Cytogenetics and Cell Genetics

Volumn 82, Issue 3-4, 1998, Pages 189-191

  Barlund M ^a,c   Nupponen, N M ^a   Karhu, R ^a   Tanner, M M ^a   Paavola, P ^b   Kallioniemi, O P ^c   Kallioniemi, A ^c  

^a TAMPERE UNIVERSITY HOSPITAL   (Finland)

^b NATIONAL PUBLIC HEALTH INSTITUTE   (Finland)

^c NATIONAL HUMAN GENOME RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CHROMOSOME 17; CHROMOSOME BREAKAGE; CHROMOSOME TRANSLOCATION; CYTOGENETICS; DNA PROBE; FLUORESCENCE IN SITU HYBRIDIZATION; HUMAN; MOLECULAR GENETICS; NONHUMAN; PRIORITY JOURNAL; QUANTITATIVE ASSAY; TELOMERE; YEAST ARTIFICIAL CHROMOSOME;

EID: 0032441583     PISSN: 03010171     EISSN: None     Source Type: Journal    
DOI: 10.1159/000015096     Document Type: Article

References (15)

1. Bärlund M, Tirkkonen M, Forozan F, Tanner MM, Kallioniemi O, Kallioniemi A: Increased copy number at 17q22→q24 by CGH in breast cancer is due to high-level amplification of two separate regions. Genes Chrom Cancer 20:372-376 (1997).
2. Guan X-Y, Meltzer PS, Dalton WS, Trent JM: Identification of cryptic sites of DNA sequence amplification in human breast cancer by chromosome microdissection. Nature Genet 8:155-161 (1994).
3. ISCN (1995): An International System for Human Cytogenetic Nomenclature (S Karger, Basel 1995).
4. Kirchweger R, Zeillinger R, Schneeberger C, Speiser P, Louason G, Theillet C: Patterns of allele losses suggest the existence of five distinct regions of LOH on chromosome 17 in breast cancer. Int J Cancer 56:193-199 (1994).
5. Kivipensas P, Björkqvist A-M, Karhu R, Pelin K, Linnainmaa K, Tammilehto L, Mattson K, Kallioniemi O-P, Knuutila S: Gains and losses of DNA sequences in malignant mesothelioma by comparative genomic hybridization. Cancer Genet Cytogenet 89:7-13 (1996).
6. Kuukasjärvi T, Karhu R, Tanner M, Kähkönen M, Schäffer A, Nupponen N, Pennanen S, Kallioniemi A, Kallioniemi O-P, Isola J: Genetic heterogeneity and clonal evolution underlying development of asynchronous metastasis in human breast cancer. Cancer Res 57:1597-1604 (1997).
7. Mascio L, Verbeek P, Kuo W-L, Gray JW: Semi-automated DNA probe mapping using digital imaging microscopy. I. Software Cytometry 19:52-60 (1994).
8. Niederacher D, Picard F, van Roeyen C, An H-X, Bender HG, Beckmann MW: Patterns of allelic loss on chromosome 17 in sporadic breast carcinomas detected by fluorescent-labeled microsatellite analysis. Genes Chrom Cancer 18:181-192 (1997).
9. Plummer SJ, Paris MJ, Myles J, Tubbs R, Crowe J, Casey G: Four regions of allelic imbalance on 17q12→qter associated with high-grade breast tumors. Genes Chrom Cancer 20:354-362 (1997).
10. Ried T, Just KE, Holt-Grez H, du Manoir S, Speicher MR, Schröck E, Latham C, Biegen H, Zetterberg A, Cremer T, Auer G: Comparative genomic hybridization of formalin-fixed, paraffin-embedded breast tumors reveals different patterns of chromosomal gains and losses in fibroadenomas and diploid and aneuploid carcinomas. Genes Chrom Cancer 55:5415-5423 (1995).
11. Sakamoto M, Pinkel D, Mascio L, Sudar D, Peters D, Kuo W-L, Yamaklawa K, Nakamura H, Drabkin H, Jericevic Z, Smith L, Gray JW: Semi-automated DNA probe mapping using digital imaging microscopy. II. System performance. Cytometry 19:61-70 (1994).
12. Tirkkonen M, Tanner M, Karhu R, Kallioniemi A, Isola J, Kallioniemi O-P: Molecular cytogenetics of primary breast cancer by CGH. Genes Chrom Cancer 21:177-184 (1998).
13. Weber RG, Boström J, Wolter M, Baudis M, Collins VP, Reifenberger G, Lichter P: Analysis of genomic alterations in benign, atypical, and anaplastic meningiomas: toward a genetic model of meningeoma progression. Proc natl Acad Sci, USA 94:14719-14724 (1997).
14. Weber-Hall S, Anderson J, McManus A, Abe S, Nojima T, Pinkerton R, Pritchard-Jones K, Shipley J: Gains, losses, and amplifications of genomic material in rhabdomyosarcoma analyzed by comparative genomic hybridization. Cancer Res 56:3220-3224 (1996).
15. Wolf FW, Marks RM, Sarma V, Byers MG, Katz RW, Shows TB, Dixit VM: Characterization of a novel tumor necrosis factor-alpha-induced endothelial primary response gene. J biol Chem 267:1317-1326 (1992).